共 85 条
[11]
Colombo P(2016)PRAGUE-18 Study Group. Prasugrel versus Ticagrelor in patients with acute myocardial infarction treated with PrimaryPercutaneous coronary intervention: multicenter randomized PRAGUE-18 study Circulation 134 1603-1606
[12]
Mafrici A(2013)Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid activity of platelet inhibitor drugs) primary PCI study J Am Coll Cardiol 61 1601-3054
[13]
Schulz S(2011)ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2999-1446
[14]
Angiolillo DJ(2000)The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptorantagonist properties Br J Pharmacol 129 1439-1047
[15]
Antoniucci D(2006)Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin Eur Heart J 27 1038-85
[16]
Mehran R(2017)A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: a network meta-analysis Cardiovasc Revasc Med 18 79-66
[17]
Rao SV(2017)Clopidogrel, prasugrel, or ticagrelor use and clinical outcome in patients with acute coronary syndrome: a nationwide long-term registry analysis from 2009 to 2014 Int J Cardiol 235 61-7
[18]
Bhatt DL(2017)The clinical efficacy and safety evaluation of ticagrelor for acute coronary syndrome in generalACS patients and diabetic patients: a systematic review and meta-analysis PLoS One 12 e0177872-199
[19]
Liberati A(2015)Comparison of platelet inhibition by prasugrel versus ticagrelor over time in patients with acute myocardial infarction J Thromb Thrombolysis 39 1-undefined
[20]
Altman DG(2012)Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel plateletreactivity following percutaneous coronary intervention: a pharmacodynamic study J Am Coll Cardiol 60 193-undefined